INTRODUCTION
The use of animal models in the study of neuropsychiatric disorders is useful in the (C) In particular, two main strategies have been adopted: (i) selection of animals based on the similarity of some of their behaviors to the human symptoms, and (ii) lesions thought to reproduce the pathogenesis of the human disease. Solanto (2000) proposed that valid models of clinical ADHD should include the following: a deficit in measures of attention and not only hyperactivity;
an improvement of both cognitive and motor deficits by stimulants and other clinically effective treatments in clinically plausible doses, an immediate onset of action and lack of tolerance or sensitization with repeated administration of drugs used to treat ADHD, and an effect of therapeutic agents on both DA and norepinephrine (NE) systems.
The various animal models proposed for the study of ADHD can be divided imo those displaying genetically derived hyperactivity/inattention, those acquiring these changes after pharmacological intervention, and those based on spontaneous variations in a random population. The models comprise mice, rats, and monkeys (see also Comings, 2001 ; Davies et al., 2001; Davids et al., 2003) .
Most studies on animal models of ADHD focus on changes in the catecholamine (DA, NE) systems, but these may represent only part of the neurobiological changes. As a matter of fact, changes in other systems such as the hippocampus (Sadile, 1993) , the hypothalamic-hypophyseal axis (Sadile, 1993; King et al., 2000) , the NE system (Russell et al., 2000 ; see also companion paper by Viggiano et al., 2004 this issue), cholinergic (Russell et al., 2000; Viggiano et al., 2003b) , and serotonin systems (Gainetdinov et al., 1999; Adriani et al., 2003) have been reported in some animal models. In particular, many toxins that give rise to a hyperDArgic behavioral profile (see also Masuo et al., 2004 this issue) are correlated to peculiar changes in the cerebellar vermis (Ferguson & Cada, 2003) , which have been reported to be present also in human ADHD (Castellanos et al., 1996) . In fact these models are grouped overall as models with 'cerebellar stunting' (Ferguson & Cada, 2003) .
The correlation with such changes and the changes in the DA system is unclear and has never been studied in detail. These changes, in fact, may arise as independent alterations, or are the result of a common cause or.could be directly connected.
Here we review the neurophysiologic and biochemical evidence for an alteration of the DA system in two rat models of ADHD, spontaneously hypertensive rats (SHR) (Tilson et al., 1977; Hendley et al., 1985; Sagvolden et al., 1993) in their own home cage and in simple mazes (L/it maze) (Aspide et al., 1996 (Sadile, 1993) , whereas novelty induced hyperactivity increases as a function of the complexity of the environment (Sadile et al., 1988 Viggiano et al., 2002b Viggiano et al., , 2003b (Viggiano & Sadile, 2000 , Viggiano et al., 2002a 2003a,b (Viggiano et al., 2002b (Viggiano et al., , 2003b and SHR rats (Watanabe et al., 1997) , in the PFc, and, at least for SHR animals, in the striatum. In synaptosomal preparations from the striatum, however, the reuptake of DA by the DAT is reduced in SHR compared with controls (Leo et al., 2003) . This would suggest that the DAT is hypofunctioning in the SHR. Therefore, in studies involving DA release from slices, the lower reuptake leads to reduced DA release, thus mimicking hypofunctioning DA terminals (Russell, 2003) .
As a consequence, less DA is cleared from the synaptic cleft and the tonic level of DA is higher, as showed by microdialysis studies in juvenile SHR animals (Howes et al., 1984; Carboni et al., 2003) . In contrast, the levels of DA in the striatum are normal in NHE rats (Carboni et al. personal communication) , whereas no data are available about the PFc.
Consistently, depletion of DA by 6-hydroxydopamine lesion of the substantia nigra of SHR decreases the magnitude of adult hypertension (van den Buuse et al., 1985 (van den Buuse et al., , 1986 Linthorst et al., 1994; de Jong et al., 1995 (Lim et al., 1989; Kirouac & Ganguly, 1993; Watanabe et al., 1997; Sadile, 1999) , whereas in NHE rats D1 mRNA is hypoexpressed in the PFc (Fig. 1) (Viggiano et al., 2002b) . The D2 receptors have been reported to be hyper-(see also Fig. 1 ), hypo-, or normoexpressed (Lim et al., 1989; Watanabe et al., 1989; Kirouac & Ganguly, 1993; Linthorst et al., 1993; Sadile, 1999; Vaughan et al., 1999; Russell et al., 2000) in the striatum of SHR, whereas their mRNA is hyperexpressed in the striatum of NHE rats, without changes in the PFc (Fig. 1) (Hellstrand, 1980; Fuller, 1983; Ueno et al., 2002 Ueno et al., 2002 Fujita, 2003) - ( > (Howes et al., 2002b (Howes et al., , 2003b (Howes et al., 1984 Carboni et al., 2003) older animals or after handling:
< (Linthorst et al., 1991; Sutoo, 1993; Nakamura, 2001; Fujita, 2003) - (Fuller, 1983; Yu, 1990; Inada, 1992; Ferguson, 2003 Viggiano et al:, 2002a Viggiano et al:, , b, ,2003a (Sadile, 2000) , although the mesocortical one might be involved as well (King et al., 2000) . In NHE rats, only the mesocortical branch appears to be involved, being hypertrophic (Viggiano & Sadile, 2000; Viggiano et al., 2002a,b; 2003a,b (Carlsson, 1975; Strombom, 1975; Doare et al., 1986) , whereas high doses are sufficient to activate directly post-synaptic receptors, thereby increasing motor activity. Therapeutic doses of methylphenidate, which are very low, should act to decrease DA-eatecholamine transmission (Seeman & Madras, 1998; Solanto, 1998 In the striatum, the resting levels of extracellular DA are 2 to 6 nM (Huff & Davies, 2002 ).
This concentration results from the balance between the opposing processes of release and uptake (Wightman, , 1990 (Annunziato et al., 1980 (Annunziato et al., , 198 l, 1984 As the concentration of DA in WKY rats has been evaluated equal to [DA] 5.17nM (Carboni et al., 2003) in the striatum, whereas the firing is f--4.SHz (Ruskin et (Schultz, 2002 (Skirboll et al., 1979; Ruskin et al., 2001) . We restricted the analysis to the effects on the firing rate, as we were interested in low doses of MPH:
Experimental data (Skirboll et al., 1979; Einhorn et al., 1988) (West & Grace, 2000; Grillner, 2002) (Fig. 2) . As shown in figure, the model reproduces the experimental data reported by (Ruskin et al., 2001 ). In fact, the blockade of the re-uptake increases extracellular DA, which acts on D2 autoreceptors, thus reducing DA neuron firing, methylphenidate has been also described to increase DA release in rats (Kalivas, 1989; Carboni et al., 2003) and humans as well (Seeman, 2002 (Linthorst et al., 1991) . The enhanced DA outflow may result from increased DA release or decreased uptake or both. In fact, synaptosome preparations from SHR rats suggested a reduction in the uptake by 28% compared to WKY (Leo et al., 2003) , although the number of DAT binding might be increased (Watanabe et al., 1997) .
Because at the steady state (df/dt=0) IDA] DF/k, the increase of [DA] might be due to a decreased effect of D2 receptors on the firing rate (k), as suggested by autoradiography studies (Sadile, 1999) (Sadile, 1999 
